Ann: Updated guidance for PAT-DX1 phase 1 clinical study, page-123

Ya gotta love a site that where veiled/blatant ramping and unsubstantiated/overtly optimistic "opinion" is tolerated but calling someone out for it is not.
Well done HC

Hi panda
yes very good valid points and is a good debate moving forward….
I think most agree that doing a new batch for dx-1 will take around 6 months and then another 3-6months of stabilisation to see if anything untoward happens again, that’s a long way off and even dx-3 could be nearer in time frames!!

Deals being done at a cheaper rate because of this? Very possible, but if deals are done because of the overwhelming data achieved so far for dx-3 and clauses put in place for the amount of IP needed to go to trials was added it would still bring in a wealth of opportunity for all concerned

At the moment Tox is the next step together with more results pending for dx-3 in the short term, I am hopeful/optimistic something of value will occur, if this was not the case I would assume the SP would already be below 1c as another 12months without possibilities of a buy-in would see us all under the 1c SP

Hoping we achieve non-dilutive funding however the dr can achieve it